share_log

華領醫藥-B：股份發行人的證券變動月報表

HUA MEDICINE-B: Monthly Return of Equity Issuer on Movements in Securities

HKEX ·  Apr 5, 2024 16:51

Summary by Moomoo AI

華領醫藥-B（02552.HK）於2024年4月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份在本月內均無變動，維持在2,000,000,000股，每股面值0.001美元，總股本為2,000,000美元。此外，根據公司股份期權計劃，本月底可行使的股份期權數目為53,797,568股，而本月內並無新股份因行使股份期權而發行。公司秘書袁頴欣確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
華領醫藥-B（02552.HK）於2024年4月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份在本月內均無變動，維持在2,000,000,000股，每股面值0.001美元，總股本為2,000,000美元。此外，根據公司股份期權計劃，本月底可行使的股份期權數目為53,797,568股，而本月內並無新股份因行使股份期權而發行。公司秘書袁頴欣確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Hua Ling Pharmaceutical-B (02552.HK) filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on April 5, 2024, reporting the change in company shares for the year ended March 31, 2024. The report shows that Hualien Pharmaceuticals' regulary/registered share capital and issued shares remained unchanged during the month at 2,000,000,000 shares with a face value of $0.001 per share and a total share capital of $2,000,000. In addition, under the Company's stock option plan, the number of share options available at the end of the month was 53,797,568 shares, and no new shares were issued during the month as a result of the exercise of the share option. COMPANY SECRETARY YUAN WING-XIN CONFIRMED THAT ALL SECURITIES ISSUANCE HAD BEEN AUTHORISED BY THE BOARD OF DIRECTORS AND COMPLIED WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.
Hua Ling Pharmaceutical-B (02552.HK) filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on April 5, 2024, reporting the change in company shares for the year ended March 31, 2024. The report shows that Hualien Pharmaceuticals' regulary/registered share capital and issued shares remained unchanged during the month at 2,000,000,000 shares with a face value of $0.001 per share and a total share capital of $2,000,000. In addition, under the Company's stock option plan, the number of share options available at the end of the month was 53,797,568 shares, and no new shares were issued during the month as a result of the exercise of the share option. COMPANY SECRETARY YUAN WING-XIN CONFIRMED THAT ALL SECURITIES ISSUANCE HAD BEEN AUTHORISED BY THE BOARD OF DIRECTORS AND COMPLIED WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    BRII-B
    02137
    -- 1.070
    CT ENTERPRISE
    03839
    -- 1.520
    FRONTAGE
    01521
    -- 1.530
    HUAKANG BIOMED
    08622
    -- 0.164
    WUXI BIO
    02269
    -- 16.480

    Unlock the Full List